Overview
Robert Sidlow is an Internal Medicine provider in New York,, New York. Dr. Sidlow is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, BRCA Positive Breast Cancer, and HER2 Negative Breast Cancer.
His clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 E 66th St, New York,, NY 10065
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mskcc Surgery Group
Debra Mangino is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Mangino is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Li-Fraumeni Syndrome, and Breast Infection.
Julie Gold is a Hematologist and an Oncologist in Mount Kisco, New York. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and HER-2 Positive Breast Cancer.
Sharon Krieger is a primary care provider, practicing in Internal Medicine in Mount Kisco, New York. Dr. Krieger is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are High Cholesterol, Obesity Hypoventilation Syndrome (OHS), Osteoporosis, and Postmenopausal Osteoporosis.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Muscle Invasive Bladder CancerDr. Sidlow isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder Cancer
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Sidlow isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- BRCA Positive Breast CancerDr. Sidlow isExperienced. Learn about BRCA Positive Breast Cancer.
- Chronic PainDr. Sidlow isExperienced. Learn about Chronic Pain.
- Gastroesophageal Junction CancerDr. Sidlow isExperienced. Learn about Gastroesophageal Junction Cancer.
- HER2 Negative Breast CancerDr. Sidlow isExperienced. Learn about HER2 Negative Breast Cancer.
- Pediatric Low-Grade Glioma (pLGG)Dr. Sidlow isExperienced. Learn about Pediatric Low-Grade Glioma (pLGG).